Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Sodium fusidate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sodium fusidate 2% ointment
1310012Q0AAAAAA
|
Sodium fusidate (Topical) | Sodium fusidate | Skin | 4,983 |
|
Fucidin 20mg/g ointment
1310012Q0BBAAAA
|
Fucidin (Topical Ointment) | Sodium fusidate | Skin | 3,065 |
|
Sodium fusidate 250mg tablets
0501070N0AAADAD
|
Sodium fusidate (Systemic) | Sodium fusidate | Infections | 300 |
|
Fucidin 250mg tablets
0501070N0BBAAAD
|
Fucidin (Injection/Powder/Tablet) | Sodium fusidate | Infections | 61 |
|
Fucidin 500mg inf vials
0501070N0BBACAB
|
Fucidin (Injection/Powder/Tablet) | Sodium fusidate | Infections | No data available |
|
Sodium fusidate 500mg inf vials
0501070N0AAABAB
|
Sodium fusidate (Systemic) | Sodium fusidate | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.